AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Return 0.94%
This Quarter Return
+3.62%
1 Year Return
+0.94%
3 Year Return
+28.58%
5 Year Return
+40.76%
10 Year Return
AUM
$270M
AUM Growth
-$3.52M
Cap. Flow
-$11.2M
Cap. Flow %
-4.15%
Top 10 Hldgs %
32.02%
Holding
1,062
New
120
Increased
240
Reduced
213
Closed
80
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VOX icon
826
Vanguard Communication Services ETF
VOX
$5.87B
$3K ﹤0.01%
33
XTN icon
827
SPDR S&P Transportation ETF
XTN
$145M
$3K ﹤0.01%
50
VIVS
828
VivoSim Labs, Inc. Common Stock
VIVS
$7.75M
$3K ﹤0.01%
4
CLR
829
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$3K ﹤0.01%
50
TIF
830
DELISTED
Tiffany & Co.
TIF
$3K ﹤0.01%
40
+5
+14% +$375
S
831
DELISTED
Sprint Corporation
S
$3K ﹤0.01%
406
-39,873
-99% -$295K
TIS
832
DELISTED
Orchids Paper Products, Inc.
TIS
$3K ﹤0.01%
100
-804
-89% -$24.1K
YHOO
833
DELISTED
Yahoo Inc
YHOO
$3K ﹤0.01%
80
BCR
834
DELISTED
CR Bard Inc.
BCR
$3K ﹤0.01%
15
WNR
835
DELISTED
Western Refining Inc
WNR
$3K ﹤0.01%
86
CPRX icon
836
Catalyst Pharmaceutical
CPRX
$2.46B
$2K ﹤0.01%
1,500
CSQ icon
837
Calamos Strategic Total Return Fund
CSQ
$3.01B
$2K ﹤0.01%
150
ABEV icon
838
Ambev
ABEV
$34.3B
$2K ﹤0.01%
300
ARGT icon
839
Global X MSCI Argentina ETF
ARGT
$745M
$2K ﹤0.01%
81
ATHE
840
Alterity Therapeutics
ATHE
$79.3M
$2K ﹤0.01%
112
-33
-23% -$589
CARM icon
841
Carisma Therapeutics
CARM
$17.3M
$2K ﹤0.01%
50
CLDX icon
842
Celldex Therapeutics
CLDX
$1.55B
$2K ﹤0.01%
33
-462
-93% -$28K
CNQ icon
843
Canadian Natural Resources
CNQ
$63B
$2K ﹤0.01%
123
EIRL icon
844
iShares MSCI Ireland ETF
EIRL
$60.6M
$2K ﹤0.01%
66
EWM icon
845
iShares MSCI Malaysia ETF
EWM
$242M
$2K ﹤0.01%
+88
New +$2K
EWT icon
846
iShares MSCI Taiwan ETF
EWT
$6.4B
$2K ﹤0.01%
+57
New +$2K
EWY icon
847
iShares MSCI South Korea ETF
EWY
$5.26B
$2K ﹤0.01%
30
FTC icon
848
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.25B
$2K ﹤0.01%
47
FULT icon
849
Fulton Financial
FULT
$3.54B
$2K ﹤0.01%
87
GREK icon
850
Global X MSCI Greece ETF
GREK
$304M
$2K ﹤0.01%
67